| Pegfilgrastim studied in …STUDIED_INderived200 of 223show all (up to 200) |
|---|
| → studied in | NCT04628767Phase 2/Phase 3 · recruiting Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer · 223 trials list this drug (34 active) | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738368Phase 2 · suspended Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia · 223 trials list this drug (34 active) | — | — | T Acute Lymphoblastic Leukemia,B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684368Phase 2 · recruiting A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT · 223 trials list this drug (34 active) | — | — | Mixed Germ Cell Tumor,Central Nervous System Nongerminomatous Germ Cell Tumor,Choriocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05645718Phase 2 · recruiting Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia · 223 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06220032Phase 3 · recruiting Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03214562Phase 1/Phase 2 · recruiting Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia · 223 trials list this drug (34 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011188Phase 1/Phase 2 · active not recruiting FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer · 223 trials list this drug (34 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535166Phase 2 · recruiting Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma · 223 trials list this drug (34 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759586Phase 3 · active not recruiting Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma · 223 trials list this drug (34 active) | — | — | Primary Mediastinal Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070564Phase 3 · active not recruiting S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · 223 trials list this drug (34 active) | — | — | Lung Large Cell Carcinoma,Lung Squamous Cell Carcinoma,Lung Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021989Phase 2 · recruiting ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma · 223 trials list this drug (34 active) | — | — | Hodgkin Lymphoma,Adult Hodgkin Lymphoma,Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147612Phase 2 · active not recruiting Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia · 223 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03943901Phase 2 · active not recruiting Split-Dose R-CHOP for Older Adults With DLBCL · 223 trials list this drug (34 active) | — | — | Malignant Neoplasm,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224100Phase 2 · recruiting Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoblastic Lymphoma,B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220022Phase 1 · active not recruiting Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas · 223 trials list this drug (34 active) | — | — | AIDS-Related Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03136146Phase 2 · recruiting Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia · 223 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Burkitt Leukemia,Lymphoblastic Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907488Phase 3 · active not recruiting Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma · 223 trials list this drug (34 active) | — | — | Classic Hodgkin Lymphoma,Lymphocyte-Rich Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064018Phase 1/Phase 2 · recruiting Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies · 223 trials list this drug (34 active) | — | — | Soft Tissue Sarcoma,Lung Non-Small Cell Carcinoma,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04174742active not recruiting Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01783535Phase 2 · active not recruiting Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma · 223 trials list this drug (34 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012297Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma · 223 trials list this drug (34 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01657331Phase 1/Phase 2 · completed Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL) · 223 trials list this drug (34 active) | — | — | Anaplastic Large Cell Lymphoma,Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07278856Phase 1 · recruiting Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas · 223 trials list this drug (34 active) | — | — | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,Follicular Helper T-Cell Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01840566Phase 1 · active not recruiting High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma · 223 trials list this drug (34 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528691Phase 2 · recruiting Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors · 223 trials list this drug (34 active) | — | — | Central Nervous System Neoplasm,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433420Phase 3 · active not recruiting Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07525869NA · recruiting An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy · 223 trials list this drug (34 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03609216Phase 2 · active not recruiting Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations · 223 trials list this drug (34 active) | — | — | Bladder Urothelial Carcinoma,Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066443Phase 1/Phase 2 · completed Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06709495Phase 1/Phase 2 · recruiting Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas · 223 trials list this drug (34 active) | — | — | Sarcoma,Ewing Sarcoma,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03301350Phase 2 · completed Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04323956Phase 1 · active not recruiting Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma · 223 trials list this drug (34 active) | — | — | Diffuse Large B-Cell Lymphoma,Indolent Non-Hodgkin Lymphoma,High Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690775Phase 2 · recruiting CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. · 223 trials list this drug (34 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma,Ovarian Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03571633Phase 2 · active not recruiting Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer · 223 trials list this drug (34 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02369458Phase 2 · completed Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies · 223 trials list this drug (34 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02909036Phase 1 · active not recruiting Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. · 223 trials list this drug (34 active) | — | — | Multiple Myeloma,Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870748Phase 2/Phase 3 · terminated REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 · 223 trials list this drug (34 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm,Ovarian Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04383743Phase 2 · completed Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer · 223 trials list this drug (34 active) | — | — | Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00911183Phase 2 · completed Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05032183Phase 1/Phase 2 · terminated Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoblastic Lymphoma,Adult Lymphoblastic Lymphoma,B Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049595Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00812669Phase 2 · completed CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7 · 223 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01437488Phase 2 · completed Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy · 223 trials list this drug (34 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04781959Phase 4 · completed A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy · 223 trials list this drug (34 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04023669Phase 1 · completed Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors · 223 trials list this drug (34 active) | — | — | Central Nervous System Neoplasm,Malignant Central Nervous System Neoplasm,Medulloblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00670358Phase 1/Phase 2 · completed Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06616571Phase 4 · recruiting Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03102606Phase 3 · completed Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520176Phase 3 · recruiting Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients · 223 trials list this drug (34 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02073097Phase 1/Phase 2 · completed Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04345900Phase 2 · completed Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00678327Phase 3 · completed Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03639948Phase 2 · unknown Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer · 223 trials list this drug (34 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00837265Phase 2/Phase 3 · completed Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05283616Phase 3 · completed Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309732Phase 2 · completed GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) · 223 trials list this drug (34 active) | — | — | Testicular Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00304070Phase 3 · completed Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor · 223 trials list this drug (34 active) | — | — | Adrenal Cortical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06188676Phase 3 · recruiting Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL · 223 trials list this drug (34 active) | — | — | Mediastinal Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004192Phase 2 · completed Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834403Phase 1/Phase 2 · completed L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients · 223 trials list this drug (34 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00679029Phase 2 · terminated Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer · 223 trials list this drug (34 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06116734Phase 3 · unknown Lapelga vs Gastrofil · 223 trials list this drug (34 active) | — | — | Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728531Phase 1 · completed Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma · 223 trials list this drug (34 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197935Phase 3 · completed A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer · 223 trials list this drug (34 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03329378Phase 2 · terminated Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00146562Phase 2 · completed Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412670Phase 2 · completed Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068393Phase 2 · completed Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma · 223 trials list this drug (34 active) | — | — | Sarcomatoid Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00074165Phase 2 · terminated Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03252431Phase 3 · completed Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04156828Phase 1 · terminated Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma · 223 trials list this drug (34 active) | — | — | Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,Follicular Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256398Phase 2 · completed Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 223 trials list this drug (34 active) | — | — | Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01126190Phase 3 · completed Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05338047Phase 2 · completed Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant · 223 trials list this drug (34 active) | — | — | Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346125NA · completed PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma · 223 trials list this drug (34 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03518112Phase 2 · terminated Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia · 223 trials list this drug (34 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02531308Phase 2 · terminated Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL) · 223 trials list this drug (34 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01319981Phase 2 · completed Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia · 223 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02943733Phase 1 · terminated Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs · 223 trials list this drug (34 active) | — | — | Neoplasm,Malignant Neoplasm,Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01879085Phase 1/Phase 2 · completed Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma · 223 trials list this drug (34 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02044276Phase 3 · completed A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02698891Phase 2 · completed Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer · 223 trials list this drug (34 active) | — | — | Early Stage Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04762901Phase 1 · withdrawn LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00887536Phase 3 · completed A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01724866Phase 2 · completed Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02643420Phase 3 · completed SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE) · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02953340Phase 3 · completed SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02467868Phase 3 · completed Efficacy and Safety Study With MYL-1401H and Neulasta · 223 trials list this drug (34 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118209Phase 3 · completed Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063999Phase 3 · completed Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer · 223 trials list this drug (34 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01847001Phase 2 · completed Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy · 223 trials list this drug (34 active) | — | — | Malignant Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00726700Phase 2 · completed Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03511378Phase 4 · completed Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290667Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392793Phase 1 · completed Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies · 223 trials list this drug (34 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03294577Phase 3 · unknown Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169636Phase 1/Phase 2 · completed Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma · 223 trials list this drug (34 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662892unknown An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00671658Phase 2 · completed Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia · 223 trials list this drug (34 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02181218Phase 1 · completed Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas · 223 trials list this drug (34 active) | — | — | Lymphoma,Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101010Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00478361Phase 2 · completed Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function · 223 trials list this drug (34 active) | — | — | Malignant Bladder Neoplasm,Malignant Urethral Neoplasm,Distal Urethral Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685111Phase 2 · terminated Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253500Phase 2 · completed Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04460079completed Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01533207Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery · 223 trials list this drug (34 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00632827Phase 2 · terminated Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) · 223 trials list this drug (34 active) | — | — | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01491841Phase 1 · completed IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma · 223 trials list this drug (34 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04227990Phase 2 · completed Plinabulin iv Solution in Prevention of TAC Induced Neutropenia · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827163Phase 2 · completed Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00394251Phase 2 · completed Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536081Phase 3 · completed Various G-CSF Regimens to Prevent Infection During Chemotherapy · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01059643Phase 2 · completed A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck · 223 trials list this drug (34 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01416389Phase 2 · completed A Study of LY2523355 in Participants With Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01266447Phase 2 · completed Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer · 223 trials list this drug (34 active) | — | — | Cervical Adenocarcinoma,Cervical Squamous Cell Carcinoma,Cervical Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00554463Phase 2 · completed G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer · 223 trials list this drug (34 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392039early Phase 1 · terminated Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00080626Phase 2 · terminated Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063934Phase 1/Phase 2 · terminated Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03559387Phase 2 · terminated Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00283621NA · completed Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide · 223 trials list this drug (34 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278161Phase 2 · completed Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma · 223 trials list this drug (34 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650193Phase 2 · completed A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body. · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00094809Phase 2 · completed Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer · 223 trials list this drug (34 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01648322Phase 2 · completed Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01355705Phase 1/Phase 2 · completed Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma · 223 trials list this drug (34 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650635Phase 1 · terminated TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors · 223 trials list this drug (34 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301925Phase 3 · unknown Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01214629Phase 1 · completed A Study for Participants With Advanced Cancer · 223 trials list this drug (34 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01214642Phase 1 · completed A Dose-Escalation Study for Patients With Advanced Cancer · 223 trials list this drug (34 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00569673Phase 2 · completed Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer · 223 trials list this drug (34 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03575520Phase 2 · completed Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557959Phase 2 · completed Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 223 trials list this drug (34 active) | — | — | Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00389818Phase 2 · completed Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392834Phase 2 · completed Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01385228Phase 1 · completed Pazopanib, Docetaxel, Prednisone Prostate · 223 trials list this drug (34 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00689884NA · terminated Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies · 223 trials list this drug (34 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01692691Phase 2 · terminated Dacarbazine and Carmustine in Metastatic Melanoma · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01654965Phase 1 · completed Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors · 223 trials list this drug (34 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01712009Phase 2 · completed NOLAN: Naproxen or Loratadine and Neulasta · 223 trials list this drug (34 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983097Phase 1/Phase 2 · terminated Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP · 223 trials list this drug (34 active) | — | — | Burkitt Lymphoma,Diffuse Large B-Cell Lymphoma,Marginal Zone Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03404752Phase 3 · unknown Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients. · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00787969Phase 1 · completed Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00911170Phase 3 · completed PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study · 223 trials list this drug (34 active) | — | — | Malignant Neoplasm,Malignant Colorectal Neoplasm,Malignant Colon Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352118Phase 2 · terminated Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer · 223 trials list this drug (34 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00404066Phase 2 · completed Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03376503Phase 1 · completed Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470366Phase 2 · completed Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors · 223 trials list this drug (34 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor,Teratoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01313884Phase 2 · terminated Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma · 223 trials list this drug (34 active) | — | — | Ewing Sarcoma,Malignant Bone Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01682044Phase 2 · completed Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma · 223 trials list this drug (34 active) | — | — | Small Lymphocytic Lymphoma,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,Grade 3 Follicular Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00151242Phase 2/Phase 3 · completed Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia · 223 trials list this drug (34 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01516736Phase 3 · completed Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00575952Phase 1 · completed Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer · 223 trials list this drug (34 active) | — | — | Endometrial Serous Adenocarcinoma,Endometrial Squamous Cell Carcinoma,Endometrial Undifferentiated Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01735175Phase 3 · completed Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® · 223 trials list this drug (34 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01594918Phase 1 · completed Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer · 223 trials list this drug (34 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856492Phase 2 · completed S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00816595Phase 2 · completed Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma · 223 trials list this drug (34 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00074178Phase 2 · completed Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00364468Phase 2 · completed Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00069953Phase 2 · completed Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction · 223 trials list this drug (34 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031629Phase 2 · completed Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus · 223 trials list this drug (34 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02782845Phase 4 · completed An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) · 223 trials list this drug (34 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01541072NA · terminated Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation · 223 trials list this drug (34 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00808639Phase 2 · completed Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma · 223 trials list this drug (34 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498588Phase 2 · terminated Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer · 223 trials list this drug (34 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107510Phase 2 · completed Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077311Phase 2 · completed Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 223 trials list this drug (34 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503984Phase 1/Phase 2 · terminated A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients · 223 trials list this drug (34 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00546377Phase 1/Phase 2 · completed Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer · 223 trials list this drug (34 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076504Phase 2 · completed A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer · 223 trials list this drug (34 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346229Phase 1 · terminated Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006011Phase 3 · completed Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer · 223 trials list this drug (34 active) | — | — | Endometrial Adenocarcinoma,Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation,Endometrial Serous Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352300Phase 1 · completed Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer · 223 trials list this drug (34 active) | — | — | Primary Peritoneal Carcinoma,Malignant Ovarian Neoplasm,Fallopian Tube Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433537Phase 2 · completed Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma · 223 trials list this drug (34 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061984Phase 3 · completed Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma · 223 trials list this drug (34 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02238873Phase 3 · unknown Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02157116Phase 2 · terminated Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer · 223 trials list this drug (34 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00306111Phase 2 · completed Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma · 223 trials list this drug (34 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119262Phase 2 · completed Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003955Phase 2 · completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma · 223 trials list this drug (34 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101127Phase 2 · completed Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma · 223 trials list this drug (34 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01639521Phase 2 · withdrawn Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer · 223 trials list this drug (34 active) | — | — | Malignant Bladder Neoplasm,Malignant Ureter Neoplasm,Malignant Urethral Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436709NA · unknown Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258634Phase 1 · terminated A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response · 223 trials list this drug (34 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00472849Phase 1/Phase 2 · completed Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias · 223 trials list this drug (34 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075634Phase 1 · completed Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma · 223 trials list this drug (34 active) | — | — | Childhood Solid Neoplasm,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00115193Phase 2 · completed Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma · 223 trials list this drug (34 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00974792Phase 2 · unknown Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00526734Phase 2 · unknown High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01172912Phase 2 · unknown High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy · 223 trials list this drug (34 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030758Phase 4 · unknown Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453232Phase 2 · completed Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors · 223 trials list this drug (34 active) | — | — | Extragonadal Germ Cell Tumor,Testicular Germ Cell Tumor,Teratoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516425Phase 3 · unknown Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410696Phase 2 · completed Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy · 223 trials list this drug (34 active) | — | — | Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00113386Phase 3 · terminated Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer · 223 trials list this drug (34 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217503Phase 2 · completed Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma · 223 trials list this drug (34 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00310089NA · completed AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00117442Phase 2 · completed A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood · 223 trials list this drug (34 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00035594Phase 3 · completed Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy · 223 trials list this drug (34 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |